Kind Patches Class Action Over Dopamine Patches

A group of consumers initiated a class action lawsuit against Kind Patches Limited. The core allegation is that the company misrepresented its transdermal dopamine patches by advertising them as containing dopamine and offering positive neurological advantages. The plaintiffs, represented by Kristen Maggi and others, contend that the patches actually consist only of herbal extracts, such as lion’s mane mushroom and rhodiola.

The lawsuit asserts that Kind Patches' marketing strategy capitalizes on consumer interest in biohacking by selling these patches online and in retail stores. Specifically, the plaintiffs claim that the representations regarding the patches containing 'dopamine' and working as advertised are a sham because the herbal ingredients are not as effective as actual dopamine or a dopamine agonist delivered transdermally. The allegations include unjust enrichment and violations of California’s Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act, as well as New York General Business Law.

The plaintiffs seek a jury trial and request monetary damages for all class members. The lawsuit is currently filed in the U.S. District Court for the Northern District of New York. The plaintiffs seek to represent anyone in the United States who purchased the patches during the applicable statute of limitations.